PHARMATEKET ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About PHARMATEKET ApS
PHARMATEKET ApS (CVR number: 15183381) is a company from VEJLE. The company recorded a gross profit of -28.6 kDKK in 2024. The operating profit was -28.6 kDKK, while net earnings were 345.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was 22.5 %, which can be considered excellent and Return on Equity (ROE) was 24.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 62.9 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. PHARMATEKET ApS's liquidity measured by quick ratio was 2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -23.00 | -23.75 | -25.00 | -27.00 | -28.63 |
EBIT | -23.00 | -23.75 | -25.00 | -27.00 | -28.63 |
Net earnings | 157.71 | 224.79 | 242.30 | 695.05 | 345.81 |
Shareholders equity total | 748.94 | 589.03 | 831.78 | 1 555.90 | 1 217.30 |
Balance sheet total (assets) | 773.94 | 879.85 | 896.10 | 1 634.14 | 1 935.28 |
Net debt | - 331.68 | -62.32 | -40.83 | -26.76 | - 693.29 |
Profitability | |||||
EBIT-% | |||||
ROA | 5.7 % | 26.9 % | 30.2 % | 54.9 % | 22.5 % |
ROE | 5.0 % | 33.6 % | 34.1 % | 58.2 % | 24.9 % |
ROI | 5.8 % | 27.8 % | 31.2 % | 56.2 % | 22.8 % |
Economic value added (EVA) | - 299.60 | -56.14 | -62.45 | -64.57 | - 102.93 |
Solvency | |||||
Equity ratio | 96.8 % | 66.9 % | 92.8 % | 95.2 % | 62.9 % |
Gearing | 45.1 % | 4.1 % | 3.1 % | 56.9 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 18.3 | 1.8 | 7.5 | 10.2 | 2.0 |
Current ratio | 18.3 | 1.8 | 7.5 | 10.2 | 2.0 |
Cash and cash equivalents | 331.68 | 328.14 | 75.15 | 75.01 | 1 386.26 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.